Skip to main content
David Robbins, MD, Endocrinology, Kansas City, KS, The University of Kansas Hospital

DavidRobbinsMD

Endocrinology Kansas City, KS

Diabetes, Lipid Metabolism, Thyroid

Prof of medicine, director KU Diabetes institute.

Dr. Robbins is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Robbins' full profile

Already have an account?

  • Office

    University of kansas school of medicine
    3901 rainbow blvd
    Kansas City, KS 64152
    Phone+1 913-588-0277
  • Is this information wrong?

Education & Training

  • University of Chicago Medical Center
    University of Chicago Medical Center1978 - 1980
  • University of Vermont Medical Center
    University of Vermont Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1976 - 1978
  • University of Vermont Medical Center
    University of Vermont Medical CenterResidency, Internal Medicine, 1974 - 1976
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1974

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2018 - 2025
  • KS State Medical License
    KS State Medical License 2005 - 2024
  • DC State Medical License
    DC State Medical License 1991 - 2006
  • MD State Medical License
    MD State Medical License 1993 - 2003
  • VT State Medical License
    VT State Medical License 1975 - 1996
  • IL State Medical License
    IL State Medical License 1978 - 1982
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Awardee Kansas University school of medicine Rainbow Award best teacher, 2008
  • Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Type 1 Diabetes: Why Cases Are Expected to Double Worldwide by 2040
    Type 1 Diabetes: Why Cases Are Expected to Double Worldwide by 2040October 5th, 2022
  • Is the Newest Diabetes Treatment Always the Best?
    Is the Newest Diabetes Treatment Always the Best?August 21st, 2017
  • Big News! FDA Votes to Show Heart Benefits on GLP-1 Agonist Victoza's Label
    Big News! FDA Votes to Show Heart Benefits on GLP-1 Agonist Victoza's LabelJune 21st, 2017

Hospital Affiliations